Overview

Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3

Status:
Terminated
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
Randomised trial of chemotherapy or not before surgery in early resectable stages of NSCLC (IB, IIA, IIB, and IIIA/N2).
Phase:
Phase 3
Details
Lead Sponsor:
Rigshospitalet, Denmark
Treatments:
Carboplatin
Paclitaxel